Healthcare -
Biotechnology - NASDAQ - CH
$ 40.72
-2.49 %
$ 2.58 B
Market Cap
-21.54
P/E
Price Target
Average
96.46%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
51.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
MoonLake Immunotherapeutics
Wall Street analysts predict an average 1-year price target for MLTX of $80 , with forecasts ranging from
a
low of
$62 to a high of $100 .
MLTX Lowest Price Target
Wall Street Target
62 USD
52.26%
MLTX Average Price Target
Wall Street Target
80 USD
96.46%
MLTX Highest Price Target
Wall Street Target
100 USD
145.58%
REVENUE FORECAST
Revenue Forecast Chart MLTX
EBIT FORECAST
EBIT Forecast Chart MLTX
NET INCOME FORECAST
Net Income Chart MLTX